Skip to main content

Seung Tae Lee, MD, PhD

Academic Title:

Associate Professor

Primary Appointment:




Phone (Primary):


Education and Training


1990: M.D., Graduated from Yonsei Univ. College of Medicine, Seoul, Korea

1995: M.S.,  Yonsei Graduate School, Seoul, KoreaThesis: Separation of CD34+ hematopoietic stem cells usingimmunomagnetic bead and avidin-biotin column.

2004: Ph.D., Cell biology, Yonsei Graduate School, Seoul, KoreaThesis: Effect of mesenchymal stem cell transplantation on the engraftment of human hematopoietic stem cells and leukemic cells in mice model

Post Graduate Education and Training:

1990 - 1991: Internship, Yonsei University College of Medicine, Seoul, Korea

1991 - 1995: Residency, internal medicine, Yonsei University College of Medicine, Seoul, Korea

1998 - 2000: Clinical Fellow, Hematology/Oncology, Yonsei University College of Medicine, Seoul, Korea

2004 - 2007: Postdoctoral fellow, department of lymphoma/myeloma, UT M.D. Anderson Cancer Center, Houston, Texas

2009 - 2011: Residency, internal medicine, Montefiore Mount Vernon Hospital,Mount Vernon, NY

2012 - present: Clinical Fellow, Hematology/Oncology Program, Division of Cancer Medicine, UT MD Anderson Cancer Center, Houston, TX.


Dr. Seung Tae Lee is a Hematology/Oncology Specialist in Baltimore, Maryland. He graduated with honors in 1990. Having more than 27 years of diverse experiences in his field.

Research/Clinical Keywords

Cancer Hematology/Oncology

Highlighted Publications

Park TS, Lee ST, Song J, Lee KA, Kim J, Kim SJ, Lee JH, Song S, Choi JR. A tandem triplication, trp(1)(q21q32), in a patient with follicular lymphoma: a case study and review of the literature. Cancer Genetics and Cytogenetics. 2009 Mar;189(2):127-31.

Park TS, Lee ST, Lee KA, Lee JH, Kim J, Lee HJ, Han JH, Kim JK, Cho SR, Choi JR. Detection of a novel CBFB/MYH11 variant fusion transcript (K-type) showing partial insertion of exon 6 of CBFB gene using two commercially available multiplex RT-PCR kits. Cancer Genetics and Cytogenetics. 2009 Mar;189(2):87-92.

Park TS, Lee ST, Song J, Lee KA, Kim J, Park Y, Song S, Choi JR. Biphenotypic acute leukemia with b2a2 fusion transcript and trisomy 21. Cancer Genetics and Cytogenetics.. 2009 Jan 15;188(2):129-31.

Park TS, Lee ST, Kim JS, Song J, Lee KA, Kim SJ, Seok YM, Lee HJ, Han JH, Kim JK, Lee EY, Choi JR. Acute promyelocytic leukemia in early pregnancy with translocation t(15;17) and variant PML/RARA fusion transcripts. Cancer Genetics and Cytogenetics. 2009 Jan 1;188(1):48-51.

Foglietta M, Neelapu SS, Kwak LW, Jiang Y, Nattamai D, Lee ST, Fowler DH, Sportes C, Gress RE, Steinberg SM, Vence LM, Radvanyi L, Dwyer KC, Qazilbash MH, Bryant RN, Bishop MR. Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients. Bone Marrow Transplant. 2013 Feb:48(2):269-77

Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS. Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma. Int J Cancer. 2014 Apr 26. [Epub ahead of print]

Research Interests